Evidence map›Paper›PMID 25945346›Full record

ReviewBioMed research international2015

Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy.

Toshihiro Nishizawa, Hidekazu Suzuki

Open access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Update on molecular pathogenesis ofWorld journal of gastrointestinal pathophysiology · 2025
    Review
  3. Increasing trend ofJournal of clinical biochemistry and nutrition · 2022
    Article
  4. Article
  5. Article
  6. Endoscopic Kyoto classification ofWorld journal of gastroenterology · 2020
    Review
  7. HER2, NF-Disease markers · 2019
    Article
  8. Introduction to serial reviews: Oxidative stress and digestive diseases.Journal of clinical biochemistry and nutrition · 2018
    Review
  9. Effects of Mulberry Fruit (Antioxidants (Basel, Switzerland) · 2018
    Review
  10. Article
  11. Article
  12. Microarray-Based Detection and Clinical Evaluation forBioMed research international · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Toshihiro NishizawaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan ; Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Hidekazu SuzukiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.ORCID 0000-0002-3855-3140
Keio University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oxygen-derived free radicals that are released from activated neutrophils are one of the cytotoxic factors of Helicobacter pylori-induced gastric mucosal injury. Increased cytidine deaminase activity in H. pylori-infected gastric tissues promotes the accumulation of various mutations and might promote gastric carcinogenesis. Cytotoxin-associated gene A (CagA) is delivered into gastric epithelial cells via bacterial type IV secretion system, and it causes inflammation and activation of oncogenic pathways. H. pylori infection induces epigenetic transformations, such as aberrant promoter methylation in tumor-suppressor genes. Aberrant expression of microRNAs is also reportedly linked to gastric tumorogenesis. Moreover, recent advances in molecular targeting therapies provided a new interesting weapon to treat advanced gastric cancer through anti-human epidermal growth factor receptor 2 (HER-2) therapies. This updated review article highlights possible mechanisms of gastric carcinogenesis including H. pylori-associated factors.

Indexed as

Cell Transformation, NeoplasticEpigenesis, GeneticGene Expression Regulation, NeoplasticHelicobacter InfectionsHelicobacter pyloriStomach NeoplasmsAnimalsAntigens, BacterialBacterial ProteinsBacterial Secretion SystemsDNA MethylationDNA, NeoplasmErb-b2 Receptor Tyrosine KinasesHumansMicroRNAsPromoter Regions, GeneticAntigens, BacterialBacterial ProteinsBacterial Secretion SystemscagA protein, Helicobacter pyloriDNA, NeoplasmERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesMicroRNAsRNA, Neoplasm

Identifiers

PMID25945346
PMCPMC4405013
OpenAlexW2079947729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.